Sort
50,496 grants matching “lung cancer”
Novel DNA damage response therapeutics targeting replication protein A
$481,424John J Turchi · Indiana University Indianapolis · R01 · FY2023 · CA
The filopodial tip complex in adhesion, migration, and signaling
$481,391Richard E Cheney · Univ Of North Carolina Chapel Hill · R01 · FY2019 · GM
Atlases to Report and Correlate Radiotherapy Dose Distributions with Outcomes
$481,389Andrew Jackson · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
Health and QOL among Long-Term Lung Cancer Survivors
$481,385Ping Yang · Mayo Clinic Rochester · R01 · FY2010 · CA
Nonmyeloablative allogeneic PBSC in globin disorders
$481,339John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Project 1 - Transformed Esophageal Epithelial Cells and the Tumor Microenvironment
$481,302Anil K Rustgi · Columbia University Health Sciences · P01 · FY2019 · CA
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
$481,288Iman Osman · New York University School Of Medicine · R01 · FY2018 · CA
Development of SHP2 inhibitors for targeted anti-cancer therapy
$481,271Zhong-Yin Zhang · Purdue University · R01 · FY2017 · CA
Washington National Primate Research Center
$481,250Mari Ostendorf · University Of Washington · P51 · FY2023 · OD
Core B - The Clinical and Biomarkers Core
$481,241Dorothy K Hatsukami · University Of Minnesota · P01 · FY2016 · CA
An Improved Red Blood Cell Storage Product and Extended Shelf Life using a Normoglycemic Additive Solution
$481,146Dana M Spence · Michigan State University · R01 · FY2021 · HL
Simultaneous dose and dose rate optimization for clinical FLASH proton radiotherapy
$481,116Hao Gao · University Of Kansas Medical Center · R01 · FY2023 · CA
A Role for KSHV in the Pathogenesis of Malignancies
$481,097Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma
$481,094David Paul Turner · Virginia Commonwealth University · R01 · FY2023 · CA
In vivo therapy and mechanisms of PAX8-PPARgamma thyroid cancer
$481,093Ronald Jay Koenig · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
Identification of Gene Polymorphisms Associated with Infectious Diseases
$481,072Cheryl Winkler · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice
$481,069Jennifer B Jacob · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2024 · CA
Screening for inhibitors of NSD3 as a treatment for lung cancer
$481,033Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Greater Denver Latino Cancer Prevention/Control Network
$480,951Estevan Tim Flores · University Of Colorado Denver · U01 · FY2006 · CA
Identification of Metabolic Vulnerabilities of Ras-Driven Cancer Cells
$480,941Eileen White · Rutgers, The State Univ Of N.J. · R01 · FY2016 · CA
Bronchoscopic Steerable Needles for Transparenchymal Access to Lung Nodules
$480,934Ron Alterovitz · Univ Of North Carolina Chapel Hill · R01 · FY2021 · EB
Synthetic lethality by targeting the core senescent mechanism in lung cancer.
$480,907Xiao-Fan Wang · Duke University · R01 · FY2022 · CA
Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS
$480,873John R Engen · Northeastern University · R01 · FY2021 · CA
Defining epithelial polarity cues that direct cell fate
$480,869Xaralabos Varelas · Boston University Medical Campus · R01 · FY2024 · HL
Irx1 regulation of oral tissue repair and maintenance.
$480,840Brad A Amendt · University Of Iowa · R56 · FY2025 · DE